Ms Salma Jabak

Ms Salma Jabak is a Consultant in Fetal Medicine and Obstetrics at the Medway Fetal and Maternal Medicine Centre, with extensive experience in managing high-risk pregnancies and complex fetal conditions. She completed her specialist training in Fetal Medicine at the Harris Birthright Research Centre for Fetal Medicine within King's College Hospital NHS Foundation Trust, where she gained advanced expertise in fetal diagnosis and invasive testing.

She previously served as Maternal Medicine Lead, Fetal Medicine Lead, and Fetal Monitoring Lead at the Princess Royal University Hospital. Her clinical practice includes the care of women with complex obstetric and medical conditions in pregnancy, as well as the diagnosis and management of fetal anomalies, fetal growth restriction, and twin pregnancies. She is highly experienced in advanced obstetric ultrasound, invasive fetal procedures including amniocentesis and CVS, and specialist antenatal care.

Ms Jabak completed her training in Obstetrics and Gynaecology at the American University of Beirut Medical Center and is on the specialist register in the UK. She has contributed to numerous academic publications and research projects in fetal and maternal medicine. Alongside her clinical work, she is actively involved in teaching undergraduate and postgraduate trainees, clinical governance, audits, and quality improvement projects.

Her approach is centred on early detection, close follow-up, and personalised, evidence-based care, with a strong focus on optimising maternal wellbeing and pregnancy outcomes for every patient.

CESR, 2025

Diploma in Fetal Medicine, Fetal Medicine Foundation, London, UK, 2019

MRCOG, London, UK, 2023

Specialist in Obstetrics and Gynaecology, American University of Beirut, Lebanon, 2016

ECFMG certification, 2013

Doctor of Medicine (MD), American University of Beirut, Lebanon, 2012

Bachelor of Science (BSc), American University of Beirut, Lebanon, 2008

Advanced obstetric ultrasound

Diagnosis and management of fetal anomalies

Assessment and management of fetal growth restriction

Twin pregnancy monitoring

Invasive fetal procedures, including amniocentesis and CVS

Specialist antenatal care for high-risk pregnancies

Care of complex obstetric and maternal medical conditions

Gnanasambanthan S, Jabak S, Mohan R, et al. The impact of socioeconomic deprivation on the prevalence of gestational diabetes: an observational study. Obstetric Medicine. 2023.

Jabak S, Hameed A. Continuous intrapartum fetal monitoring in gestational diabetes, where is the evidence? J Matern Fetal Neonatal Med. 2022 Nov;35(22):4354-4357. DOI: 10.1080/14767058.2020.1849117. PMID: 33307915.

Ciobanou A, Jabak S, De Castro H, Frei L, Akolekar R, Nicolaides KH. Biomarkers of impaired placentation at 35-37 weeks' gestation in the prediction of adverse perinatal outcome. Ultrasound Obstet Gynecol. 2019 Jul;54(1):79-86. DOI: 10.1002/uog.20346. PMID: 31100188.

Vigneswaran T, Jabak S, Syngelaki A, Charakida M, Simpson JM, Nicolaides KH, Zidere V. Prenatal incidence of isolated right aortic arch and double aortic arch. J Matern Fetal Neonatal Med. 2021;34(18):2985-2990. DOI: 10.1080/14767058.2019.1676413.

Jabak S, Vigneswaran TV, Charakida M, Kasapoglu T, de Jesus Cruz J, Simpson JM, Zidere V. Initial experience of Superb Microvascular Imaging for key cardiac views in foetal assessment before 15 weeks gestation. Fetal Diagn Ther. 2020;47(4):268-276. DOI: 10.1159/000502839. PMID: 31597155.

Management of high-risk pregnancies

Fetal medicine and prenatal diagnosis

Maternal medicine and complex medical conditions in pregnancy

Fetal growth restriction

Twin pregnancies

Fetal cardiac imaging

Teaching, clinical governance and quality improvement

Contact us now to book an appointment.